Scarica l'app Stockscreener
12.42
0.48%
-0.06
Precedente Chiudi:
$12.48
Aprire:
$12.51
Volume 24 ore:
22,175
Relative Volume:
3.08
Capitalizzazione di mercato:
$533.36M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$12.36
$13.00
Intervallo di 1 settimana:
$9.02
$13.47
Portata 52W:
$9.02
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Nome
Jade Biosciences Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta JBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
12.50 | 533.36M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.39 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
611.04 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.99 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.23 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
253.12 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Non sono disponibili dati finanziari per Jade Biosciences Inc (JBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Jade Biosciences Inc Azioni (JBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dake Benjamin T | SEE REMARKS |
Aug 01 '24 |
Option Exercise |
1.74 |
1,507 |
2,622 |
14,252 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 17 '24 |
Buy |
1.67 |
928,110 |
1,549,944 |
7,893,678 |
| Eldridge George A | SEE REMARKS |
Jun 14 '24 |
Option Exercise |
2.14 |
15,000 |
32,100 |
20,022 |
| Eldridge George A | SEE REMARKS |
Jun 14 '24 |
Sale |
25.03 |
15,000 |
375,450 |
5,022 |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER |
Jun 14 '24 |
Option Exercise |
14.59 |
10,600 |
154,654 |
10,600 |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER |
Jun 14 '24 |
Sale |
25.00 |
10,600 |
265,000 |
0 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
Jun 13 '24 |
Option Exercise |
2.14 |
6,000 |
12,840 |
11,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
Jun 13 '24 |
Sale |
24.50 |
6,000 |
147,000 |
5,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
May 17 '24 |
Option Exercise |
2.14 |
4,000 |
8,560 |
9,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
May 17 '24 |
Sale |
21.08 |
4,000 |
84,332 |
5,602 |
0.58%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):